BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14606340)

  • 21. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
    Gupta AK; Paquet M
    Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream.
    Shaffelburg M
    J Drugs Dermatol; 2009 Jan; 8(1):35-9. PubMed ID: 19180894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating actinic keratoses with imiquimod.
    Dixon A
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imiquimod (Aldara) for actinic keratoses.
    Med Lett Drugs Ther; 2004 May; 46(1183):42-4. PubMed ID: 15159659
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
    Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
    Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
    Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].
    Cerburkovas O; Krause M; Ulrich J; Bonnekoh B; Gollnick H
    Hautarzt; 2001 Oct; 52(10 Pt 2):942-6. PubMed ID: 11715389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines of care for the management of actinic keratosis: Executive summary.
    Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
    J Am Acad Dermatol; 2021 Oct; 85(4):945-955. PubMed ID: 34111497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is imiquimod effective and safe for actinic keratosis?
    Walker JK; Koenig C
    J Fam Pract; 2003 Mar; 52(3):184-5. PubMed ID: 12620165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
    Samrao A; Cockerell CJ
    Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines of care for the management of actinic keratosis.
    Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
    J Am Acad Dermatol; 2021 Oct; 85(4):e209-e233. PubMed ID: 33820677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pitfalls of treating all actinic keratoses as squamous cell carcinomas.
    Wheeland RG
    Semin Cutan Med Surg; 2005 Sep; 24(3):152-4. PubMed ID: 16202952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
    Flowers F
    Int J Dermatol; 2002 May; 41 Suppl 1():12-5. PubMed ID: 12087813
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.
    Rivers JK; Arlette J; Shear N; Guenther L; Carey W; Poulin Y
    Br J Dermatol; 2002 Jan; 146(1):94-100. PubMed ID: 11841372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and novel treatment options for actinic keratosis.
    Jorizzo JL
    J Cutan Med Surg; 2004; 8 Suppl 3():13-21. PubMed ID: 15647860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
    Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
    Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.